SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
SEC Accession No. 0000950123-17-001877
Filing Date
2017-02-14
Accepted
2017-02-13 20:02:27
Documents
2
Period of Report
2016-12-31
Effectiveness Date
2017-02-14

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 13F-HR  
1 primary_doc.xml 13F-HR 2305
2 INFORMATION TABLE FOR FORM 13F form13fInfoTable.html INFORMATION TABLE  
2 INFORMATION TABLE FOR FORM 13F form13fInfoTable.xml INFORMATION TABLE 2440
  Complete submission text file 0000950123-17-001877.txt   5939
Mailing Address 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE LUXEMBOURG N4 L-1528
Business Address 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE LUXEMBOURG N4 L-1528 352 26449 557
Pharmstandard International S.A. (Filer) CIK: 0001598762 (see all company filings)

IRS No.: 000000000
Type: 13F-HR | Act: 34 | File No.: 028-17790 | Film No.: 17601802